<html>
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no" />
    <meta http-equiv="X-UA-Compatible" content="ie=edge">
    <title>乳腺癌临床实验</title>
    <link rel="stylesheet" href="./comment.css">
    <link rel="stylesheet" href="./index.css">
</head>
<body>
    <ul>
        <a href="./test/fourthTest.html"><li>一项旨在患有HER2阳性转移性乳腺癌或局部晚期乳腺癌，并且既往接受过曲妥珠单抗和紫杉烷类药物治疗转移性疾病的中国患者中，比较trastuzumab emtansine与卡培他滨加拉帕替尼的安全性和有效性的III期、随机、多中心、开放性临床试验（BO29919）</li><a/>
    </ul>
</body>
</html>